Global Trade Compliance Manager - Sanctions Screening and Clinical Valuation Lead

Career Category Compliance

Job Description

JOIN AMGEN’S MISSION OF SERVING PATIENTS At Amgen, if you feel like you are a part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do. Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases.

With our focus on four therapeutic areas – Oncology, Inflammation, General Medicine, and Rare Disease – we reach millions of patients each year. As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives. Our award-winning culture is collaborative, innovative, and science based.

If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career. Global Trade Compliance Manager - Sanctions Screening and Clinical Valuation Lead Live What you will do: Sanctions and Ownership Screening In this role, you will serve as the global screening lead responsible for executing and continuously improving Amgen’s sanctions and ownership compliance framework under: U.

S. Department of Treasury – Office of Foreign Assets Control (OFAC) U. S.

Department of Commerce – Bureau of Industry & Security (BIS) Other global regulatory agencies You will act as the primary escalation point for sanctions screening alerts involving counterparties, transactions, and ownership structures. This includes responsibility for analyzing complex corporate ownership chains to determine applicability of OFAC’s 50% aggregation rule and BIS Entity List/ MEU (Military End User) ownership requirements.

Partnering cross-functionally with Compliance, Legal, Sourcing, Finance, Operations, and Business Units, you will help ensure Amgen’s global activities are conducted in full compliance with international trade laws while mitigating regulatory, financial, and reputational risk. This role combines investigative rigor, regulatory experience, data analysis, and process innovation.

Responsibilities

Sanctions & 50% Ownership Screening Oversight Serve as subject matter expert on OFAC 50% Ownership aggregation principles and BIS 50% Entity List alignment

requirements

Conduct enhanced due diligence on counterparties to determine ultimate beneficial ownership (UBO) Aggregate ownership interests across direct and indirect shareholders to assess sanctions exposure Screen vendors, customers, banks, and other counterparties against: OFAC SDN List BIS Entity List / Military End User Lists Other applicable restricted party lists Review, analyze, and adjudicate screening alerts; determine true matches vs.

false positives.

Responsibilities

Responsible for supporting global customs clinical valuation assignments by ensuring accurate customs valuation in compliance with international trade regulations. Apply knowledge of trade compliance

requirements

to support global clinical valuation activities Support the assignment of customs values for clinical materials in accordance with World Customs Organization (WCO) valuation principles Review dashboards for new product setup and demand forecasts to anticipate valuation needs and prioritize activities Support year-end true-up activities for global clinical customs valuation and ensure new values in SAP are entered accurately and timely Partner with internal stakeholders to ensure customs values for new clinical materials are accurately entered in SAP Win What we expect of you We seek a professional who combines regulatory expertise, analytical rigor, and sound judgment with the ability to operate in a dynamic global environment.

experience

in compliance or screening operations, risk management, regulatory affairs, audit, law, or a related field OR Associate’s degree and 8 years of

experience

in compliance, risk management, regulatory affairs, audit, law, or a related field OR High school diploma / GED and 10 years of

experience

in compliance, risk management, regulatory affairs, audit, law, or a related field Preferred Qualifications: Basic understanding of WCO customs valuation principles and international trade compliance Strong knowledge of: OFAC sanctions regulations and 50% aggregation rule BIS Entity List / MEU

requirements

Experience

conducting ownership due diligence and UBO investigations Familiarity with sanctions screening platforms (e.g., Dow Jones, Descartes, MK Denial, Sayari, Kharon, SAP GTS, Oracle GTM) Advanced analytical

skills

and ability to interpret complex ownership structures

Experience

preparing investigative reports for senior leadership Proficiency in compliance systems, analytics tools, and AI-enabled monitoring solutions Strong project management capabilities Excellent written and verbal communication

skills

Demonstrated ability to work independently while collaborating across a global matrix High ethical standards and professional integrity Adaptable and eager to learn new technologies and regulatory trends impacting regional compliance High ethical standards, integrity, and sensitivity to diverse groups, with the ability to influence and resolve conflict constructively . Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.

This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit www. amgen. com and follow us on www.

twitter.